Product ID:DYNALOY 340
MSDS Date:12/01/1989
FSC:8010
NIIN:00N051668
MSDS Number: BVFGM

DYNALOY INC

7 GREAT MEADOW LANE
HANOVER, NJ 07936
US

Emergency Phone: 201-887-9270

Info Phone: 201-887-9270

Preparer: JAY W. PARTON

Cage: 27905

DYNALOY, INC.

INDIANAPOLIS, IN 46203 US

Telephone: 317-788-9925;703-527-3887

Cage: 27908

ACRYLIC RESIN

CAS: 9010-88-2

Fraction By Weight: 13-23%

OSHA PEL 0.01 MG/M3 (MFR)

ACGIH TLV: 2 MG/M3 (MFR)

SILVER; (METALLIC SILVER PIGMENT) (SARA III)

CAS: 7440-22-4

RTECS: VW3500000

Fraction By Weight: 35-55%

OSHA PEL 0.01 MG/M3

ACGIH TLV: 0.1 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

XYLENE (SARA III)

CAS: 1330-20-7

RTECS: ZE2100000

Fraction By Weight: 2-12%

OSHA PEL 100 PPM

ACGIH TLV: 100 PPM; 150 STEL

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

ETHANOL, 2-METHOXY-; (ETHYLENE GLYCOL MONOMETHYL ETHER)

CAS: 109-86-4

RTECS: KL5775000

Fraction By Weight: 5-20%

OSHA PEL 25 PPM, S

ACGIH TLV: 5 PPM, S

ETHANOL, 2-BUTOXY; (2-BUTOXYETHANOL) (SARA III)

CAS: 111-76-2

RTECS: KJ8575000

Fraction By Weight: 5-20%

OSHA PEL 50 PPM, S

ACGIH TLV: 25 PPM, S

LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: MODERATELY TOX. EYE, SKIN &
RESP TRACT IRRIT. HDCH, DIZZ, DROW, FATG, NAUS, VOMIT, DIGESTIVE
TRACT IRRIT, DIARR, WEAK, TREMORS, CONFUSN, INCOORDINATION, KIDNEY
&/OR LUNG DMG, RED BLOOD CELL HEM OLYSIS. CHRONIC:ETHYLENE GLYCOL
MONOMETHYL ETHER APPEARS ON NAVY LIST OF OCCUP CHEM REPRO HAZS.
SEEK (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:HLTH HAZ: CONSULTATION FROM APPROP HLTH
PROFESSIONALS CONCERNING LATEST HAZ LIST INFO & SAFE HNDLG & EXPOS
INFO ANIMAL STUDIES HAVE SHOWN DOSE-RELATED ADVERSE EFTS TO CNS,
HEMATOPOIETIC TISS, B LOOD, KIDNEY & LIVER ASSOC W/ADMIN OF
2-BUTOXYETHANOL (EXTRACTED FROM DHHS (NIOSH) PUBLICATION NO 90-118
(SUPDAT)
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN CONDITIONS.
BREATHING OF VAPOR &/OR MIST MAY AGGRAVATE ASTHMA & INFLAMMATORY OR
FIBROTIC PULMONARY DISEASE.

First Aid:INHAL: REMOVE TO FRESH AIR. IF BREATHING HAS STOPPED, GIVE
ARTF RESP. IF BREATHING IS DIFFICULT, GIVE OXYGEN. CALL MD. EYES:
FLUSH W/WATER FOR AT LEAST 15 MINUTES, INCLUDING UNDER THE EYELIDS.
GET IMM EDIATE MEDICAL ATTENTION. SKIN: REMOVE CONTAMINATED
CLOTHING & FLUSH SKIN W/WATER. FOLLOW BY WASHING W/SOAP & WATER.
CALL MD. INGEST: DO NOT INDUCE VOMITING. GET IMMEDIATE MEDICAL
ATTENTION.

Flash Point Method:CC
Flash Point:81.0F,27.2C
Extinguishing Media:CARBON DIOXIDE, DRY CHEMICAL.
Fire Fighting Procedures:USE NIOSH/MSHA APPROVED SCBA AND FULL
PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:VAPORS MAY TRAVEL & BE IGNITED BY SPARKS,
FLAMES, PILOT LIGHTS, SMOKING, ELECTRICAL EQUIPMENT OR OTHER
SOURCES AT A DISTANCE.

Spill Release Procedures:WEAR PROT EQUIP. EXTINGUISH & DO NOT TURN ON
ANY IGNIT SOURCE UNTIL AREA IS DETERM TO BE FREE FROM EXPLO/FIRE
HAZS. SM SPILLS SHOULD BE FLUSHED W/LG QTYS OF WATER. LG SPILLS
SHOULD BE COLLECTED FOR DI SPOSAL. AVOID DISCHARGING TO
SEWERS/WATERWAYS.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling and Storage Precautions:KEEP AWAY FROM HEAT & FLAME. KEEP
CONTAINER CLOSED. USE WITH ADEQUATE VENTILATION.
Other Precautions:WARNING! HARMFUL IF INHALED OR ABSORBED THROUGH SKIN.
CAUSES EYE & SKIN IRRITATION. FLAMMABLE. DO NOT BREATHE VAPOR. DO
NOT GET IN EYES, ON SKIN OR CLOTHING. ACCIDENTAL CONTACT SHOULD BE
WASHED AWAY I MMEDIATELY.

Respiratory Protection:USE A NIOSH/MSHA APPROVED SUPPLIED AIR
RESPIRATOR (SELF-CONTAINED OR AIR-LINE) FOR HIGH CONCENTRATIONS.
Ventilation:WELL VENTILATED AREA. MECHANICAL (GENERAL): EXHAUST HOOD.
USE EXPLOSION PROOF EQUIPMENT.
Protective Gloves:CHEM RESISTANT GLOVES (BUTYL RUBBER).
Eye Protection:ANSI APPRVD CHEM WORKER GOGGLES .
Other Protective Equipment:PROTECTIVE APRON, EMER EYE WASH AND DELUGE
SHOWER WHICH MEET ANSI DESIGN CRITERIA .
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
EFTS OF OVEREXP: RPTD OVEREXP MAY CAUSE INJURY TO BONE MARROW & BLOOD
CELLS, LIVER & TESTIS. IN LAB STUDIES OF ETHYLENE GLYCOL MONOBUTYL
ETHER, ANIMALS RECEIVING RPTD DOSES DEVELOP HEMOLYTIC ANEMIA &
SECONDARY INJURY TO KIDNEY & LIVER.

Appearance and Odor:SILVER COLORED LIQUID; SOLVENT ODOR.

Stability Indicator/Materials to Avoid:YES
OXIDIZERS, ACIDS, BASES, AMINES.
Stability Condition to Avoid:HEAT, SPARKS, FLAME, IGNITION SOURCES.
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE.

Waste Disposal Methods:INCINERATE IN A FURNACE WHERE PERMITTED UNDER
APPROPRIATE FEDERAL, STATE AND LOCAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.